SOLICITATION NOTICE
65 -- FDA Approved Microsphere Embolization Particles for William Beaumont Army Medical Center - W81K00-17-T-M037
- Notice Date
- 5/19/2017
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- Department of the Army, U.S. Army Medical Command, REGIONAL HEALTH CONTRACT OFF CENTRAL, ATTN: MCAA GP L31 9V, 2539 GARDEN AVENUE, JBSA FT SAM HOUSTON, Texas, 78234-0000, United States
- ZIP Code
- 78234-0000
- Solicitation Number
- W81K00-17-T-M037
- Archive Date
- 6/17/2017
- Point of Contact
- Brenda M. Ferjak,
- E-Mail Address
-
brenda.m.ferjak.civ@mail.mil
(brenda.m.ferjak.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- Combined Synopsis and Solicitation This is a combined synopsis and solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested. The requirement is for FDA Approved Microsphere Embolization Particles for use in trans-arterial embolization procedures for William Beaumont Army Medical Center that meet the essential physical characteristics listing in the solicitation. This solicitation and resultant purchase order is being conducted as unrestricted under full and open competition. All responsible sources may submit an offer which shall be considered by the government. ***Please see attachment for full combined synopsis/solicitation.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/MEDCOM/DADA09/W81K00-17-T-M037/listing.html)
- Place of Performance
- Address: William Beaumont Army Medical Center, El Paso, Texas, 79920, United States
- Zip Code: 79920
- Zip Code: 79920
- Record
- SN04515171-W 20170521/170519234228-4d8da1411b22d27ef57b1bbf4a46fd50 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |